Steminent Biotherapeutics (ROCO:7729) EPS (Basic) : NT$-2.84 (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics EPS (Basic)?

Steminent Biotherapeutics's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-1.34. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.84.

Steminent Biotherapeutics's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-1.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.84.

Steminent Biotherapeutics's EPS without NRI for the six months ended in Dec. 2024 was NT$-1.34. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.84.

During the past 3 years, the average EPS without NRI Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Steminent Biotherapeutics's highest 3-Year average EPS without NRI Growth Rate was 6.90% per year. The lowest was -39.20% per year. And the median was -16.15% per year.

Steminent Biotherapeutics EPS (Basic) Historical Data

The historical data trend for Steminent Biotherapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics EPS (Basic) Chart

Steminent Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-0.99

-3.52

-1.92

-2.67

-2.84

Steminent Biotherapeutics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial			-1.22	-0.94	-1.73	-1.50	-1.34

Steminent Biotherapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Steminent Biotherapeutics's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-158.748	-	0)	/	55.897
	=	-2.84

Steminent Biotherapeutics's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-75.145	-	0)	/	55.983
	=	-1.34

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.84

Steminent Biotherapeutics (ROCO:7729) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Steminent Biotherapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445

Website

http://www.steminent.com

Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines